The study sought to characterize the efficacy of stellate ganglion block (SGB) as a treatment for electrical storm (ES).
percutaneously to the stellate ganglion, which is less invasive than CSD and can be performed at bedside in emergent setting in patients with hemodynamic instability Currently, besides case reports and small series, limited evidence is available regarding the role of SGB in ES . To better understand the role of SGB in ES (particularly to address patient characteristics, techniques, and overall efficacy of SGB), we performed dedicated published data searches and performed this systemic review. Comparison of CMY subtypes was performed using analysis of variance, and arrhythmia subtypes were compared using the KruskalWallis test, as these data were non-normally distributed. A p value <0.05 was considered significant.
RESULTS
PATIENT CHARACTERISTICS. A total of 3,374 publications were reviewed and 38 patients from 23 studies published between 1976 and 2016 were included based on inclusion and exclusion criteria.
The mean age of the patient population was 52 AE 19.1 years. Twenty-seven (71%) patients were men. CMY was present in 24 (63.2%) patients (ischemic CMY in 17 patients and nonischemic CMY in 7 patients) ( Table 1 ). The mean LVEF was 31 AE 10%. Acute myocardial infarction was the most common trigger of ES (15 patients), followed by prolonged QT interval (7 patients). Interestingly, intracranial hemorrhage was the etiology in 2 patients. In 37% of patients, the 
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Stellate Ganglion Block and Electrical Storm trigger of ES was unspecified. Of the arrhythmia types, mixed VT-VF was the most common type encountered (n ¼ 15), followed by polymorphic VT (n ¼ 12). Four patients had monomorphic VT and 7 patients had primary VF without VT ( Table 1) .
Almost all patients were treated with beta-blocker therapy (33 of 38). All patients except 1 received antiarrhythmic medications before SGB ( Table 2 ) and the most common agents were amiodarone (82%) and lidocaine (68%). On average, 1.82 AE 0.82 antiarrhythmic drugs were used, along with beta-blockers or calcium-channel blockers, before SGB. Regarding other interventions before SGB, 36.8% patients were intubated and deeply sedated, whereas 15.8% patients were treated with catheter-based ablation (Table 3) .
APPROACH TO SGB. SGB was achieved by administering local anesthetic percutaneously to the stellate ganglion. We examined the delivery method, the type and amount of local anesthetic, and the use of imaging guidance with SGB. Thirty-four patients received only left SGB whereas in 4 patients both left and right SGB were performed. As noted in Table 4 , local anesthetic agents were administered as bolus injections in 28 (73.7%) patients, whereas continuous infusion with pump system was used in 9 patients (1 patient had both bolus and continuous infusion). Among patients receiving bolus injections, bupivacaine was the most commonly used anesthetic in patients with SGB (n ¼ 16), while ropivacaine was the next most commonly used. The mean volume of bupivacaine used was 9.0 AE 5.6 ml with concentration ranging from 0.25% to 0.50%. We also examined the use of imaging when performing SGB.
Ultrasound guidance was used in 21 patients and fluoroscopy was used in 4 patients ( Table 4 ). In the remaining 13 patients, SGB was performed with anatomic landmarks only without imaging guidance. Values are n (%).
ECMO ¼ extracorporeal membrane oxygenation; IABP ¼ intra-aortic balloon pump; TEA ¼ thoracic epidural anesthesia. Values are n (%).
Stellate Ganglion Block and Electrical Storm ICMY ¼ ischemic cardiomyopathy; NICMY ¼ nonischemic cardiomyopathy. Table 5 . All poor responders were men and presented with polymorphic VT. Mean LVEF in this group was 27 AE 13%.
Following SGB, 80.6% of patients survived to discharge (hospital day 6 to 28), and terminal sympathectomy via surgical CSD was performed in 11 patients. One patient underwent orthotopic heart transplantation.
DISCUSSION
The major findings of the present study on the efficacy of SGB for ES are: 1) SGB is effective in reducing the number of episodes and therapies for VA; and 2) this efficacy was independent of the subtype of VA, the presence or absence of CMY, and the degree of LV dysfunction in the patients studied. To our knowledge, this is the first systemic review of the efficacy of SGB in patients with ES, and strongly supports the use of SGB in patients with ES.
There is a strong link between cardiac sympathetic Values are n, mean AE SD, or n (%).
Abbreviations as in Table 1 .
Meng et al. We present the most commonly used approaches, anesthetic agents, and doses to achieve SGB. The patient characteristics and technical data generated by the present study may be helpful as a reference for the institution of SGB. These data may also be useful in the design and patient selection for randomized prospective studies to improve SGB techniques in clinical practice.
STUDY LIMITATIONS. This study has a number of limitations, which include the number of studies in the published data meeting inclusion or exclusion criteria. As these were predominantly case reports and case series, data reported here are retrospective.
Further, the small sample size limits potentially instructive subgroup analyses, as well as the reliability of the analyses made. To improve the accuracy of the present study, reports in the published data lacking basic patient demographics were excluded, reducing the overall number of patients in the study.
CONCLUSIONS
The findings of the present study support the routine use of SGB as an effective adjunct to contemporary therapies in managing ES. SGB is efficacious for a variety of VA subtypes and patient demographics.
Prospective randomized studies are needed to better understand the role of the SGB in ES and other VA. 
